Page last updated: 2024-08-23

piperacillin and vancomycin

piperacillin has been researched along with vancomycin in 205 studies

Research

Studies (205)

TimeframeStudies, this research(%)All Research%
pre-199010 (4.88)18.7374
1990's30 (14.63)18.2507
2000's33 (16.10)29.6817
2010's89 (43.41)24.3611
2020's43 (20.98)2.80

Authors

AuthorsStudies
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M1
How, D; Mansour, TS; Newman, H; Petersen, PJ; Sum, PE; Torres, N1
Ashcroft, J; Graziani, EI; How, D; Koehn, FE; Mansour, TS; Petersen, PJ; Sum, PE; Torres, N1
Kwon, DH; Lu, CD1
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P1
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG1
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z1
Brown-Driver, V; Finn, J; Haselbeck, RJ; Hilgers, MT; Kedar, GC; Reyes, DR; Shaw, KJ; Stidham, MA1
Lombardo, F; Obach, RS; Waters, NJ1
Biek, D; Ge, Y; Sahm, DF; Talbot, GH1
Karlowsky, JA; Laing, NM; Zhanel, GG1
Jacobus, NV; McDermott, LA; Snydman, DR1
Bradford, PA; Jones, CH; Mansour, TS; Petersen, PJ; Projan, SJ; Venkatesan, AM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH1
Hanberger, H1
Casewell, MW; Fagan, E; Philpott-Howard, J; Rolando, N; Wade, JJ; Williams, R1
Andremont, A; Boutan-Laroze, A; Culine, S; Droz, JP; Kattan, J; Ribrag, V1
Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P1
Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V1
Hida, S; Matsuda, T; Takeuchi, H; Yoshida, O; Yu, MD1
Kelsey, SM; Newland, AC; Shaw, E1
Chow, AW; Cole, CD; Jewesson, PJ; Kureishi, A; Phillips, GL; Reece, DE; Rubinger, M; Smith, JA1
Fontana, R; Grossato, A; Ligozzi, M; Tonin, EA1
Fuursted, K2
Chandrasekar, PH; Levine, DP; Price, S1
Baltch, AL; Bassey, C; Fanciullo, G; Smith, RP1
Claeys, G; Van den Abeele, AM; Verschraegen, G1
Anaissie, EJ; Bodey, GP; Cabanillas, F; Elting, L; Fainstein, V; Kantarjian, H; McCredie, KB; Rolston, K1
Hall, WC; Hunter, BH; Merritt, J1
Milatović, D1
Calderwood, SB; Jackson, E; Tung, CC1
Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K1
Betschel, S; Kreiswirth, B; Low, DE; Willey, BM1
Althoff, PH; Fischer, M; Stern, M1
Abs, L; Bekradda, M; Culine, S; Droz, JP; Farhat, F; Kattan, J1
Kinzig, M; Sörgel, F1
Hamada, S; Ooshima, T; Yoshida, T1
Capeyron, O; Demotes-Mainard, F; Dupon, M; Janvier, G; Saric, J; Vinçon, G; Winnock, S1
Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C1
Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G1
Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C1
Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A1
Palmer, SM; Rybak, MJ1
Fraser, SL; Jorgensen, JH1
Collatz, E; Gutmann, L; Mainardi, JL; Rybkine, T; Sougakoff, W1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM1
Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G1
Chan, YS; Chao, EK; Lee, SS; Shin, CH; Ueng, SW; Wang, CJ1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R1
Chen, JY; Lin, CP; Lin, SR; Sun, CY; Tsai, MC1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I1
Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW1
Baddour, LM; Googe, PB; Prince, TL1
Chua, A; Jimenez, VE; Tortora, G; Younus, F1
Beilman, GJ; Feltis, BA; Lee, DA1
Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C1
Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S1
Chin, NX; Della-Latta, P; Libre, PE1
Glasmacher, A; Wade, JC1
Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM1
Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D1
Etches, W; Lee, B; Robinson, JL; Saxinger, L; Stang, L; Tawfik, G1
Carmeli, Y; Flores, EL; Lin, MY; Sreeramoju, P; Tolentino, J; Weber, SG; Zumsteg, J1
Howell, JM; Mohammadi, A1
Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A1
Aronowitz, P; London, V1
MacDougall, C; Oinonen, M; Pakyz, AL; Polk, RE1
Al Hassan, M; Byrd, RP; Halawa, A; Roy, TM; Yacoub, G1
Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P1
Chun, ED; Collins, CD; Malani, PN; Rodgers, PE; Vitale, CA1
Foley, RJ; Kannan, S; Kourelis, T1
Hsu, RW; Hsu, WH; Peng, KT1
Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR1
Anand, A; Chauhan, HK1
Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH1
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö1
Jawitz, RS; Krach, K; Schapiro, B1
Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL1
Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E1
Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS1
Fett, N; Kovarik, CL; Wanat, KA1
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK1
Adamson, RT; Amara, S; Huang, X; Lew, I1
Leung, E; Ly, SC; Scheetz, MH; Venkatesan, N1
Finnegan, PM; Hand, S; Linneman, TW; McDonald, JR; Moenster, RP; Thomas, Z1
Dilworth, TJ; Dodd, M; Mercier, RC; Ryan, K; Sliwinski, J1
Fortier, LC; Garneau, JR; Valiquette, L1
Feng, X; He, L; He, Y; Li, C; Liu, H; Liu, X; Ruan, Y; Wu, X; Zhang, Y1
Jamal, JA; Lipman, J; Roberts, JA; Udy, AA1
Birch, A; Della Vecchia, BJ; Dupree, L; Gomes, DM; Jankowski, CA; Kraemer, DF; Smotherman, C1
Burgess, LD; Drew, RH1
Dilworth, TJ; Leonard, SN; Mercier, RC; Vilay, AM1
Chen, PL; Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wu, CJ; Wu, YH; Yeh, FH1
Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Joundi, RA; Leis, JA; Wong, BM1
Baines, C; Brown, B; Lewis, I; Smart, D1
Cury, JD; Dakkak, M; Siddiqi, F1
Bose, S; Popovich, MJ; Silver, BJ; Wurm, E1
Listernick, R1
Anderson, AM; Easley, K; Kandiah, S; Kim, T; Patel, M; Rab, S; Wong, J; Xue, W1
Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN1
El-Ibiary, S; Gorlitsky, B1
Fodero, KE; Horey, AL; Krajewski, MP; Mergenhagen, KA; Ruh, CA; Sellick, JA1
Manek, M; O'Donnell, JN; Rhodes, NJ; Scheetz, MH; Venkatesan, N1
Cohen, H; Peyko, V; Smalley, S1
Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN1
Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N1
Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M1
Abraham, MK; Crouter, AJ; Wilkerson, RG1
Ahrens, CL; Bauer, SR; Bollinger, JE; Harinstein, LM; Petite, SE1
Mellen, CK; Rindone, JP; Ryba, JE1
Giuliano, CA; Kale-Pradhan, PB; Patel, CR1
Burgess, DR; Burgess, DS; Cox, JN; Martin, CA; Rutter, WC1
Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J1
Evans, R; Hussain, T; Karino, S; Kaye, KS; Koons, J; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Perry, W; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N1
Cai, Y; Haddad, J; Saqi, A1
Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H1
Dubrovskaya, Y; Louie, E; Mousavi, M; Papadopoulos, J; Scipione, MR; Zapolskaya, T1
Burgess, DR; Burgess, DS; Rutter, WC; Talbert, JC1
Burgess, DS; Rutter, WC1
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N1
Manian, FA1
Kaye, KS; Navalkele, B; Pogue, JM1
LeCleir, LK; Pettit, RS1
Farber, JL; Filippone, EJ; Kraft, WK1
Hincapie Castillo, J; Jeon, N; Klinker, KP; Staley, B; Winterstein, AG1
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD1
Effraim, P; Li, L; Tham, SW; Waxman, S1
Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM1
Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ1
Awdishu, L1
Bryan, M; Cowden, C; Downes, KJ; Fisher, BT; Goldstein, SL; Gong, W; Huang, YS; Laskin, BL; Zaoutis, TE1
Deresinski, S; Watkins, RR1
Kempker, RR; Kumar, S; Mgbemena, O; Serota, DP; Weiss, DS; Wozniak, JE1
Caffrey, AR; Dosa, D; LaPlante, KL; Lodise, TP; Luther, MK; Timbrook, TT1
Abouelkheir, M; Alsubaie, S1
Beckman, EJ1
Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD1
Adondakis, MG; Brown, EM; Oliver, MR; Skedros, JG1
Jaffer, ZN; Nicholson, C1
Jafri, SM; Nemakayala, DR; Rai, MP; Rayamajhi, S1
Downes, KJ; Fisher, BT; Laskin, BL1
Jhaveri, R; Willis, ZI1
Arıcı, M; Balcı, C; Hayran, SA; Ünal, S; Uzun, Ö; Yüce, D1
Asano, T; Hirano, S; Imai, S; Kushiya, H; Miyasaka, D; Nakamura, T; Nakanishi, Y; Noji, T; Okamura, K; Shichinohe, T; Tanaka, K; Tsuchikawa, T1
Gopalakrishnan, M; John, JF; Manappallil, RG; Nambiar, H1
Keller, F1
Leong, D; Wu, PE1
Bergstrom, C; Gupta, A; Nagalla, S1
Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E1
Castellazzi, ML; Claut, LE; Colombo, C; Daccò, V; Esposito, S1
An, G; Creech, B; Fissell, WH; Groszek, JJ; Marsh, E; Patel, P; Shotwell, M; Verhoven, SM1
Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S1
Banerjee, R; Esbenshade, AJ; Quach, HT; Zhao, Z1
Juang, P; Kollef, MH; Micek, ST1
Avedissian, SN; Liu, J; Pais, GM; Rhodes, NJ; Scheetz, MH1
Avedissian, SN; Chalkias, A; d'Aloja, E; Downes, KJ; Fitzgerald, JC; Gilchrist, A; Hiner, D; Liu, J; Locci, E; Lodise, TP; Pais, GM; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Xanthos, T; Zuppa, AF1
Campanile, A; Ciarambino, T; Giannico, OV; Giordano, M; Para, O; Signoriello, G; Tirelli, P1
Kächele, M; Keller, F1
Becker, A; Braun, E; Chaudier, P; Chidiac, C; Corbin, K; Dupieux, C; Ferry, T; Fessy, MH; Goutelle, S; Gunst, S; Laurent, F; Lustig, S; Mabrut, E; Triffault-Fillit, C; Valour, F1
Blyth, DM; Campbell, WR; Ganesan, A; Petfield, JL; Robben, PM; Shaikh, F; Stewart, L; Tribble, DR; Yabes, JM1
DeMott, JM; Hammond, DA; Peksa, GD; Traversa, A1
Grabein, B; Liebchen, U; Paal, M; Scharf, C; Schroeder, I; Siebers, C; Zander, J; Zoller, M1
Brüggemann, RJ; de Wildt, SN; Kolwijck, E; Kramers, C; Schouten, JA; Workum, JD1
Egge, JA; Heintz, BH; Lee, JD; Livorsi, DJ; Lund, BC; Mosher, HJ1
Canouï, E; Chouchana, L; Contejean, A; Kerneis, S; Tisseyre, M; Treluyer, JM1
Lin, FJ; Shao, CH; Tai, CH; Wang, CC; Wang, JT; Wu, CC1
Chiasson, JM; Cutrell, JB; Jodlowski, TZ; Kouma, MA; Smith, WJ1
Burdette, SD; Elliott, BP; Madden, JA; Markert, RJ; Pleiman, CM; Speelmon, EC; Tang, MM1
Bansal, R; Deshpande, AA; Jagia, P; Sharma, V1
Imai, T; Kakeya, H; Kawaguchi, H; Nagayama, K; Nakamura, Y; Oshima, K; Sakurai, N; Shibata, W; Yamada, K; Yamashita, Y; Yano, T1
Duong, L; Harriott, NG; Ives, AL; Pan-Chen, S; Rungkitwattanakul, D1
Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K; Yagi, T1
Li, T; Liu, K; Mao, H; Ni, J; Wu, B; Xing, C; Xu, X; Zhang, Y1
Aizawa, F; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izumi, Y; Nakamoto, A; Okada, N; Yagi, K; Zamami, Y1
Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS1
Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P1
Chen, CH; Chen, YC; Chen, YT; Huang, WC; Lai, TS; Lee, KH; Shao, SC; Su, CH; Sung, JM; Wang, MT1
Imai, S; Kadomura, S; Kashiwagi, H; Miyai, T; Sato, Y; Sugawara, M; Takekuma, Y1
Bian, L; He, K; Liang, W; Lv, J; Wu, Z; Yue, H1
Baczek, SM; Cohen, JA; Hodge, LA; Ingemi, AI; Kaplan, MC; Kiley, PS; Pearston, AP; Shaeffer, ZA; Soriano, KM; Stanley, JS; Talt, IE; Wilson, TJ; Yao, A1
Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T1
Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C1
Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC1
Côté, JM; Kane-Gill, SL; Murray, PT1
Carta, N; Décaudin, B; Degand, F; Gaudy, R; Genay, S; Lebuffe, G; Martin Mena, A; Maury, É; Négrier, L; Odou, P; Thibaut, M1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y1
Cai, Q; Cao, Y; Chen, C; Gao, P; Hou, FF; Hu, Y; Johnson, DW; Kong, Y; Li, G; Li, H; Liu, B; Liu, H; Liu, X; Lu, F; Nie, S; Shen, J; Shi, Y; Su, G; Tang, Y; Wan, Q; Weng, J; Xiao, C; Xie, D; Xu, G; Xu, H; Xu, X; Yang, Q; Zha, Y; Zhou, Y1
Chai, MG; Cotta, MO; Farkas, A; Roberts, JA1
Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA1
Armengol de la Hoz, MÁ; Becker, CD; Calvachi-Prieto, P; Celi, LA; Chen, AY; Chen, C; Dagan, A; Deng, CY; Johnson, AEW; Khazi-Syed, A; Scurlock, C1
Furuya, K; Ito, K; Makio, S; Shimada, T; Sugiyama, K1
Ajithkumar, VT; Geeta, MG; Krishnan, C; Raj, A; Rajesh, TV; Shabina, MPB1
Cotta, MO; Elhadi, M; Farkas, A; Imani, S; Kanji, S; Luque-Pardos, S; Roberts, JA; Sanches, C; Sandaradura, I; Scheetz, MH; Schellack, N; Tabah, A; Timsit, JF; Wilks, K; Williams, PG; Xie, J1
Barreto, EF; Chang, J; Lesnicki, E; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K1
Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R1

Reviews

14 review(s) available for piperacillin and vancomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Enterococcis: pathogens of the 90s.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1994
Pharmacokinetic characteristics of piperacillin/tazobactam.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors; Tissue Distribution; Tobramycin; Vancomycin

1994
Mycotic aneurysm of the descending thoracic aorta caused by Pseudomonas aeruginosa in a solid organ transplant recipient: case report and review.
    Surgical infections, 2002,Spring, Volume: 3, Issue:1

    Topics: Adult; Aneurysm, Infected; Aortic Aneurysm, Thoracic; Aztreonam; Blood Vessel Prosthesis Implantation; Debridement; Drug Therapy, Combination; Humans; Infusions, Parenteral; Male; Organ Transplantation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Secondary Prevention; Treatment Outcome; Vancomycin

2002
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
    Current drug safety, 2017, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin

2017
Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
    Pharmacotherapy, 2016, Volume: 36, Issue:12

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin

2016
The Nephrotoxicity of Vancomycin.
    Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:3

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin

2017
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies.
    Current opinion in critical care, 2017, Volume: 23, Issue:6

    Topics: Acute Kidney Injury; Critical Illness; Disease Susceptibility; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Renal Replacement Therapy; Risk Factors; Vancomycin

2017
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
    Critical care medicine, 2018, Volume: 46, Issue:1

    Topics: Acute Kidney Injury; Adult; Critical Care; Drug Therapy, Combination; Humans; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Vancomycin

2018
[Pharmacotherapy and kidney dysfunction].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2019, Volume: 114, Issue:5

    Topics: Anti-Bacterial Agents; Critical Illness; Glomerular Filtration Rate; Humans; Kidney Diseases; Meropenem; Pharmacokinetics; Piperacillin; Vancomycin

2019
Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review.
    Internal and emergency medicine, 2020, Volume: 15, Issue:2

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin; Tazobactam; Vancomycin

2020
[Pharmacokinetics and pharmacodynamics in extracorporeal renal replacement therapy].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2021, Volume: 116, Issue:4

    Topics: Anti-Bacterial Agents; Critical Illness; Humans; Meropenem; Piperacillin; Renal Dialysis; Renal Replacement Therapy; Vancomycin

2021
Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
    Clinical therapeutics, 2021, Volume: 43, Issue:10

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Drug Therapy, Combination; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin

2021
Nephrotoxins and acute kidney injury - The consensus of the Taiwan acute kidney injury Task Force.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:5

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Anti-Bacterial Agents; Anticoagulants; Consensus; Contrast Media; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Retrospective Studies; Taiwan; Vancomycin

2022

Trials

16 trial(s) available for piperacillin and vancomycin

ArticleYear
An open, comparative trial of aztreonam with vancomycin and gentamicin with piperacillin in patients with fulminant hepatic failure.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Aztreonam; Drug Therapy, Combination; Female; Gentamicins; Humans; Liver Failure; Male; Middle Aged; Piperacillin; Treatment Outcome; Vancomycin

1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin

1992
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin

1992
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Piperacillin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1992
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclosporine; Double-Blind Method; Drug Interactions; Female; Fever; Glycopeptides; Humans; Kidney Diseases; Male; Middle Aged; Neutropenia; Piperacillin; Teicoplanin; Tobramycin; Vancomycin

1991
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    The American journal of medicine, 1988, Volume: 84, Issue:3 Pt 2

    Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Vancomycin

1988
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    The American journal of medicine, 1996, Jun-24, Volume: 100, Issue:6A

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin

1996
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
    American journal of hematology, 1998, Volume: 58, Issue:4

    Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Piperacillin; Prospective Studies; Time Factors; Vancomycin

1998
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin

1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin

1999
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Aug-01, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin

2003
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
    Cancer treatment reviews, 2004, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin

2004
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Surgical infections, 2005,Spring, Volume: 6, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection

2005
Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
    Acta haematologica, 2014, Volume: 132, Issue:1

    Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infection Control; Length of Stay; Leukemia, Myeloid, Acute; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin

2014
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:7

    Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin

2019

Other Studies

175 other study(ies) available for piperacillin and vancomycin

ArticleYear
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis

1999
Synthesis and activity of novel benzoxazole derivatives of mannopeptimycin glycopeptide antibiotics.
    Bioorganic & medicinal chemistry letters, 2003, Aug-04, Volume: 13, Issue:15

    Topics: Anti-Bacterial Agents; Benzoxazoles; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Enterococcus; Glycopeptides; Gram-Positive Bacteria; Indicators and Reagents; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship

2003
Synthesis and evaluation of ether and halogenated derivatives of mannopeptimycin glycopeptide antibiotics.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Ether; Glycopeptides; Gram-Positive Bacteria; Halogens; Microbial Sensitivity Tests; Structure-Activity Relationship

2003
Polyamine effects on antibiotic susceptibility in bacteria.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus

2007
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
    Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship

2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance

2008
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin

2008
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Proteins; Drug Resistance, Bacterial; Fosfomycin; Inhibitory Concentration 50; Microbial Sensitivity Tests; RNA, Antisense

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States

2008
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests

2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests

2008
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan

2010
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea

2010
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
    European journal of medicinal chemistry, 2021, Nov-15, Volume: 224

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship

2021
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Scandinavian journal of infectious diseases. Supplementum, 1992, Volume: 81

    Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin

1992
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Bulletin du cancer, 1992, Volume: 79, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Piperacillin; Prospective Studies; Renal Insufficiency; Vancomycin

1992
[Urinary tract infection caused by Corynebacterium sp.--a case report and an experimental study].
    Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:4

    Topics: Administration, Oral; Animals; Corynebacterium Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Minocycline; Piperacillin; Rats; Rectal Fistula; Urinary Bladder Calculi; Urinary Bladder Fistula; Urinary Tract Infections; Vancomycin

1992
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cell Wall; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Microbial Sensitivity Tests; Penicillins; Peptides; Piperacillin; Vancomycin

1990
Further studies on post-antibiotic effect and synergism in two strains of Streptococcus faecalis.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1989, Volume: 97, Issue:1

    Topics: Ampicillin; Drug Synergism; Enterococcus faecalis; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Streptomycin; Time Factors; Tobramycin; Vancomycin

1989
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:2

    Topics: Ampicillin; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Enterococcus faecalis; Glycopeptides; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Streptococcus; Teicoplanin; Vancomycin

1985
In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefsulodin; Clindamycin; Drug Combinations; Drug Synergism; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Naphthyridines; Oxacillin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin

1987
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin

1988
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
    Chemotherapy, 1988, Volume: 34, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Imipenem; Piperacillin; Streptococcus; Streptomycin; Thienamycins; Vancomycin

1988
Lack of mezlocillin and piperacillin interference in measurement of vancomycin in the Abbott TDx.
    Clinical chemistry, 1987, Volume: 33, Issue:12

    Topics: Drug Interactions; Humans; Mezlocillin; Piperacillin; Vancomycin

1987
Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:2

    Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefotaxime; Cefotiam; Clindamycin; Doxycycline; Humans; Neutrophils; Penicillin G; Penicillins; Phagocytosis; Piperacillin; Staphylococcus aureus; Vancomycin

1982
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
    Journal of clinical microbiology, 1984, Volume: 19, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin

1984
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:3

    Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin

1984
[Severe infection by methicillin-resistant staphylococci after insertion of PEG].
    Deutsche medizinische Wochenschrift (1946), 1995, Aug-25, Volume: 120, Issue:34-35

    Topics: Aged; Aged, 80 and over; Enteral Nutrition; Female; Gastrostomy; Gentamicins; Humans; Injections, Intravenous; Methicillin Resistance; Metronidazole; Piperacillin; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
    Bulletin du cancer, 1994, Volume: 81, Issue:10

    Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Sulbactam; Vancomycin

1994
Detection of caries-inducing microorganisms in hyposalivated rats without infection of mutans streptococci.
    Microbiology and immunology, 1994, Volume: 38, Issue:1

    Topics: Animals; Dental Caries; Dietary Carbohydrates; Drug Resistance, Microbial; Erythromycin; Lactobacillus; Male; Mouth; Penicillins; Piperacillin; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Staphylococcus aureus; Sucrose; Vancomycin; Xerostomia

1994
Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.
    European journal of clinical pharmacology, 1993, Volume: 45, Issue:6

    Topics: Adolescent; Adult; Aged; Bile; Chromatography, High Pressure Liquid; Female; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Piperacillin; Premedication; Vancomycin

1993
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:5

    Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin

1996
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:9

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin

1996
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin

1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin

1997
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Flavobacterium; Fluoroquinolones; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Reproducibility of Results; Vancomycin

1997
Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:1

    Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Bacterial Proteins; beta-Lactam Resistance; Carrier Proteins; Drug Resistance, Microbial; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Sequence Homology, Amino Acid; Vancomycin

1998
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
    Pathologie-biologie, 1998, Volume: 46, Issue:6

    Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin

1998
Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting.
    The Journal of trauma, 1998, Volume: 45, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Bone Transplantation; Chronic Disease; Debridement; Drug Carriers; Female; Fractures, Ununited; Humans; Male; Middle Aged; Osteomyelitis; Piperacillin; Polymethyl Methacrylate; Tibial Fractures; Transplantation, Autologous; Vancomycin

1998
Stability of self-prepared fortified antibiotic eyedrops.
    The Kaohsiung journal of medical sciences, 1999, Volume: 15, Issue:2

    Topics: Anti-Bacterial Agents; Drug Stability; Microbial Sensitivity Tests; Ophthalmic Solutions; Piperacillin; Temperature; Vancomycin

1999
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin

2000
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
    Shock (Augusta, Ga.), 2000, Volume: 14, Issue:3

    Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries

2000
Possible role of cellular immunity: a case of cellulitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1

    Topics: Cellulitis; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Middle Aged; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Vancomycin

2001
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
    The Journal of infection, 2002, Volume: 45, Issue:2

    Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin

2002
Antiendotoxin activity of antimicrobial peptides and glycopeptides.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Penicillins; Piperacillin; Proteins; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Teicoplanin; Vancomycin

2003
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.
    Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:9

    Topics: Anti-Bacterial Agents; Endophthalmitis; Enzyme Inhibitors; Eye; Half-Life; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin

2003
Cervical spondylodiscitis from an ingested pin: a case report.
    Journal of pediatric surgery, 2005, Volume: 40, Issue:3

    Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating

2005
Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Drug Combinations; Drug Incompatibility; Drug Interactions; Drug Stability; Heparin; Humans; Partial Thromboplastin Time; Piperacillin; Vancomycin

2005
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11

    Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin

2005
Sternal tuberculosis.
    The Journal of emergency medicine, 2009, Volume: 36, Issue:4

    Topics: Abscess; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Ofloxacin; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sternum; Thorax; Tomography, X-Ray Computed; Tuberculosis; Vancomycin

2009
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
    JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:10

    Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin

2007
Purpuric rash of meningococcemia.
    Journal of hospital medicine, 2008, Volume: 3, Issue:2

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Bacteremia; Ceftriaxone; Humans; Hydrocortisone; Male; Meningococcal Infections; Middle Aged; Neisseria meningitidis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein C; Purpura; Recombinant Proteins; Vancomycin

2008
Trends in antibacterial use in US academic health centers: 2002 to 2006.
    Archives of internal medicine, 2008, Nov-10, Volume: 168, Issue:20

    Topics: Academic Medical Centers; Adult; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin

2008
Dacryocystitis: an unusual form of Mucorales infection.
    The Journal of the Kentucky Medical Association, 2008, Volume: 106, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Dacryocystitis; Enzyme Inhibitors; Female; Humans; Mucorales; Mucormycosis; Penicillanic Acid; Piperacillin; Tazobactam; Tobramycin; Vancomycin

2008
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
    Journal of Korean medical science, 2008, Volume: 23, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin

2008
Antimicrobial use among patients receiving palliative care consultation.
    The American journal of hospice & palliative care, 2010, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Decision Making; Drug Utilization; Female; Humans; Infections; Male; Michigan; Middle Aged; Palliative Care; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin

2010
An unusual case of septic shock in a geriatric patient.
    Connecticut medicine, 2010, Volume: 74, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins

2010
Improved antibiotic impregnated cement prosthesis for treating deep hip infection: a novel design using hip compression screw.
    The Journal of arthroplasty, 2010, Volume: 25, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Bone Screws; Cohort Studies; Female; Follow-Up Studies; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Piperacillin; Prosthesis Design; Prosthesis-Related Infections; Radiography; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin

2010
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2

    Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine

2011
Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient.
    Platelets, 2011, Volume: 22, Issue:4

    Topics: Anti-Bacterial Agents; Antibodies; Blood Platelets; Cellulitis; Humans; Male; Middle Aged; Piperacillin; Platelet Count; Thrombocytopenia; Vancomycin

2011
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
    American journal of surgery, 2011, Volume: 201, Issue:3

    Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin

2011
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
    International journal of medical sciences, 2011, Volume: 8, Issue:4

    Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin

2011
A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
    Archives of dermatology, 2011, Volume: 147, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Drug Eruptions; Eosinophils; Female; Humans; Immunoglobulin A; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Vesiculobullous; Vancomycin

2011
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:4

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin

2012
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:4

    Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin

2012
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Critical care medicine, 2012, Volume: 40, Issue:5

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin

2012
Pustular eruption in the ICU.
    The American journal of medicine, 2012, Volume: 125, Issue:8

    Topics: Acute Generalized Exanthematous Pustulosis; Amputation, Surgical; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Humans; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Vancomycin

2012
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    The Journal of surgical research, 2013, Volume: 181, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries

2013
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
    Current medical research and opinion, 2013, Volume: 29, Issue:7

    Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin

2013
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jul-01, Volume: 70, Issue:13

    Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Combinations; Drug Stability; Humans; Infusions, Intravenous; Isotonic Solutions; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Vancomycin

2013
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:6

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Diabetes Complications; Drug Therapy, Combination; Humans; Incidence; Middle Aged; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2014
Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2014
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
    BMC infectious diseases, 2014, Jan-15, Volume: 14

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin

2014
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Critical care medicine, 2014, Volume: 42, Issue:7

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Piperacillin; Renal Replacement Therapy; Thienamycins; Vancomycin

2014
Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
    Pharmacotherapy, 2014, Volume: 34, Issue:7

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin

2014
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Pharmacotherapy, 2014, Volume: 34, Issue:7

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2014
Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
    Clinical therapeutics, 2014, Oct-01, Volume: 36, Issue:10

    Topics: Anti-Bacterial Agents; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2014
Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
    Anaerobe, 2014, Volume: 30

    Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clostridium; Clostridium Infections; Cytomegalovirus Infections; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Vancomycin Resistance

2014
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin

2015
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
    JAMA internal medicine, 2015, Volume: 175, Issue:4

    Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin

2015
Performance of the Baxter Infusor LV10 under hyperbaric conditions.
    Diving and hyperbaric medicine, 2015, Volume: 45, Issue:1

    Topics: Anti-Bacterial Agents; Ceftriaxone; Dopamine; Elastomers; Hyperbaric Oxygenation; Infusion Pumps; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Temperature; Time Factors; Vancomycin

2015
Broncholithiasis presenting as bronchiectasis and recurrent pneumonias.
    BMJ case reports, 2015, Jun-23, Volume: 2015

    Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchiectasis; Bronchoalveolar Lavage; Chest Pain; Dyspnea; Female; Fever; Humans; Lithiasis; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Recurrence; Treatment Outcome; Vancomycin

2015
Drug-induced immune-mediated thrombocytopenia in the intensive care unit.
    Journal of clinical anesthesia, 2015, Volume: 27, Issue:7

    Topics: Device Removal; Female; Humans; Immunoglobulin G; Intensive Care Units; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Purpura, Thrombocytopenic, Idiopathic; Vancomycin

2015
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male; Pancytopenia; Penicillanic Acid; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sacrococcygeal Region; Tazobactam; Vancomycin

2015
Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
    BMC research notes, 2015, Oct-17, Volume: 8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam; Vancomycin

2015
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
    Surgical infections, 2016, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin

2016
A Common But Not so Typical Elevated Anion Gap.
    The American journal of medicine, 2016, Volume: 129, Issue:5

    Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin

2016
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
    Clinical therapeutics, 2016, Volume: 38, Issue:3

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Drug Therapy, Combination; Female; Hospital Departments; Humans; Interrupted Time Series Analysis; Male; Middle Aged; Patient Safety; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Veterans

2016
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Feb-15, Volume: 73, Issue:4

    Topics: Anti-Bacterial Agents; Chemical Precipitation; Drug Compounding; Drug Incompatibility; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sodium Chloride; Time Factors; Vancomycin

2016
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:2

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin

2017
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Pharmacotherapy, 2016, Volume: 36, Issue:5

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2016
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
    Anaerobe, 2016, Volume: 42

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin

2016
Emphysematous pyelonephritis in a renal allograft.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:3

    Topics: Anti-Bacterial Agents; Comorbidity; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Therapy, Combination; Emphysema; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Norepinephrine; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Pyelonephritis; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin

2017
Antimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra-Abdominal Infections.
    Pharmacotherapy, 2016, Volume: 36, Issue:11

    Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin

2016
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2017
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
    BMC infectious diseases, 2016, Dec-12, Volume: 16, Issue:1

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin

2016
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jan-15, Volume: 64, Issue:2

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Retrospective Studies; Risk; Severity of Illness Index; Vancomycin

2017
Spontaneous Nasal Septal Abscess Presenting as a Soft Tissue Mass in a Child.
    The Journal of emergency medicine, 2017, Volume: 52, Issue:4

    Topics: Abscess; Amoxicillin; Anti-Bacterial Agents; Child; Emergency Service, Hospital; Epistaxis; Fever; Humans; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Nasal Septum; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rupture, Spontaneous; Tomography, X-Ray Computed; Vancomycin

2017
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:1

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin

2017
Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Pharmacotherapy, 2017, Volume: 37, Issue:3

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cohort Studies; Creatinine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin

2017
Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
    Journal of hospital medicine, 2017, Volume: 12, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2017
Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
    Pharmacotherapy, 2017, Volume: 37, Issue:5

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin

2017
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Le infezioni in medicina, 2017, Mar-01, Volume: 25, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin

2017
Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1

    Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Reply to Manian.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1

    Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2017, Volume: 52, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2017
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult

2017
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
    Clinical therapeutics, 2017, Volume: 39, Issue:8

    Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult

2017
Between fire and ice: refractory hypothermia and warmth-induced pain in inherited erythromelalgia.
    BMJ case reports, 2017, Jul-26, Volume: 2017

    Topics: Anti-Bacterial Agents; Child; Cold Temperature; Erythromelalgia; Female; Furosemide; Hot Temperature; Humans; Hypothermia; Mutation, Missense; NAV1.7 Voltage-Gated Sodium Channel; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyethylene Glycols; Rewarming; Skin Diseases, Vesiculobullous; Sodium Potassium Chloride Symporter Inhibitors; Surface-Active Agents; Thyroxine; Treatment Outcome; Vancomycin

2017
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Military medicine, 2017, Volume: 182, Issue:9

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin

2017
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017, Volume: 18, Issue:12

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2017
Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    JAMA pediatrics, 2017, 12-04, Volume: 171, Issue:12

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Factual; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; United States; Vancomycin

2017
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Nov-29, Volume: 65, Issue:12

    Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin

2017
Peculiar purulence: Hypervirulent Klebsiella pneumoniae causing pyomyositis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Abscess; Male; Middle Aged; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyomyositis; Vancomycin

2017
Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam.
    Pediatrics international : official journal of the Japan Pediatric Society, 2018, Volume: 60, Issue:2

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin

2018
Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up?
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017, Volume: 18, Issue:12

    Topics: Acute Kidney Injury; Child; Critical Illness; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
    Critical care (London, England), 2017, 12-20, Volume: 21, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin

2017
    BMJ case reports, 2018, Feb-12, Volume: 2018

    Topics: Anti-Bacterial Agents; Bursitis; Debridement; Elbow Injuries; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Olecranon Process; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium acnes; Soft Tissue Injuries; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin

2018
Bullous eyelid.
    BMJ case reports, 2018, Feb-22, Volume: 2018

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Diagnosis, Differential; Eyelid Diseases; Eyelids; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Streptococcal Infections; Streptococcus pyogenes; Vancomycin

2018
Role Of Conservative Management In Emphysematous Gastritis.
    BMJ case reports, 2018, Feb-23, Volume: 2018

    Topics: Adult; Anti-Bacterial Agents; Conservative Treatment; Emphysema; Female; Fluid Therapy; Gastric Mucosa; Gastritis; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tomography, X-Ray Computed; Vancomycin

2018
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply.
    JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5

    Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin

2018
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment.
    JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5

    Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin

2018
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:2

    Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Logistic Models; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Thienamycins; Vancomycin

2018
The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.
    Surgery today, 2018, Volume: 48, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cefmetazole; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Period; Male; Middle Aged; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Retrospective Studies; Surgical Wound Infection; Tazobactam; Time Factors; Vancomycin

2018
Pyopericardium progressing to tamponade in a patient with immune thrombocytopenia.
    BMJ case reports, 2018, May-16, Volume: 2018

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cardiac Tamponade; Disease Progression; Drainage; Female; Humans; Penicillanic Acid; Pericardial Effusion; Pericarditis, Constrictive; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin

2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam.
    JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8

    Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.
    JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8

    Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

2018
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:5

    Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult

2018
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis.
    Italian journal of pediatrics, 2018, Aug-15, Volume: 44, Issue:1

    Topics: Child, Preschool; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Early Diagnosis; Eosinophilia; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Osteomyelitis; Piperacillin; Pneumonia, Bacterial; Risk Assessment; Sampling Studies; Tobramycin; Vancomycin; Withholding Treatment

2018
Beta-lactam carryover in arterial and central venous catheters is negligible.
    Clinica chimica acta; international journal of clinical chemistry, 2018, Volume: 486

    Topics: Animals; Catheters, Indwelling; Cattle; Cefepime; Central Venous Catheters; Chromatography, High Pressure Liquid; Meropenem; Piperacillin; Vancomycin

2018
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin

2019
Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 03-17, Volume: 70, Issue:7

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2020
Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-11, Volume: 71, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Vancomycin

2020
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
    The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin

2020
Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
    The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cohort Studies; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2020
Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use.
    Journal of intensive care medicine, 2021, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Lactams; Piperacillin; Retrospective Studies; Risk Factors; Vancomycin; Young Adult

2021
Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients.
    Journal of pharmacy practice, 2021, Volume: 34, Issue:6

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2021
The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
    Journal of critical care, 2020, Volume: 60

    Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Cross-Sectional Studies; Drug Monitoring; Germany; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Physicians; Piperacillin; Surveys and Questionnaires; Treatment Outcome; Vancomycin

2020
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.
    The Journal of antimicrobial chemotherapy, 2021, 01-01, Volume: 76, Issue:1

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Vancomycin

2021
Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Clostridioides; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2021
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis.
    The Journal of antimicrobial chemotherapy, 2021, 04-13, Volume: 76, Issue:5

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Pharmacovigilance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2021
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:1 Pt 1

    Topics: Acute Kidney Injury; Humans; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Vancomycin

2022
Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Culture; Cohort Studies; Humans; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin; Veterans

2022
A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin-tazobactam versus vancomycin cefepime.
    Internal and emergency medicine, 2022, Volume: 17, Issue:1

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin

2022
Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet (London, England), 2021, 06-12, Volume: 397, Issue:10291

    Topics: Abscess; Anti-Bacterial Agents; Cardiac Tamponade; Humans; Male; Pericardiocentesis; Pericardium; Piperacillin; Pneumopericardium; Tazobactam; Tuberculosis, Lymph Node; Vancomycin; Young Adult

2021
Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:11

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin

2021
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem.
    Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:2

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2022
Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:12

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Teicoplanin; Vancomycin

2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
    Clinical therapeutics, 2021, Volume: 43, Issue:11

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bayes Theorem; Cefepime; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin

2021
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
    Journal of critical care, 2022, Volume: 67

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin

2022
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
    Journal of neonatal-perinatal medicine, 2022, Volume: 15, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin

2022
Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:7

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Big Data; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2022
    Surgical infections, 2022, Volume: 23, Issue:8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aorta; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thrombocytopenia; Vancomycin

2022
Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
    Antimicrobial agents and chemotherapy, 2022, 08-16, Volume: 66, Issue:8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Incidence; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2022
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin

2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin

2023
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
    Therapeutic drug monitoring, 2023, 04-01, Volume: 45, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin

2023
A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?
    Intensive care medicine, 2022, Volume: 48, Issue:9

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2022
Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates.
    International journal of pharmaceutics, 2022, Nov-05, Volume: 627

    Topics: Anti-Bacterial Agents; Drug Incompatibility; Infusions, Intravenous; Infusions, Parenteral; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin

2022
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains.
    Anaerobe, 2022, Volume: 78

    Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella

2022
Piperacillin/tazobactam and risk of acute kidney injury in adults hospitalized with infection without vancomycin: a multi-centre real-world data analysis.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:1

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Ceftazidime; Data Analysis; Drug Therapy, Combination; Female; Humans; Meropenem; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2023
Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients.
    The Journal of antimicrobial chemotherapy, 2023, 02-01, Volume: 78, Issue:2

    Topics: Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Humans; Meropenem; Piperacillin; Sepsis; Software; Vancomycin

2023
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
    The Journal of antimicrobial chemotherapy, 2023, 02-01, Volume: 78, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult

2023
A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
    Chest, 2023, Volume: 164, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2023
A case of Robinsoniella peoriensis bacteremia during using piperacillin-tazobactam.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:9

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Female; Fever; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin

2023
    Tropical doctor, 2023, Volume: 53, Issue:4

    Topics: Anti-Bacterial Agents; Child; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Piperacillin; Vancomycin

2023
International survey of antibiotic dosing and monitoring in adult intensive care units.
    Critical care (London, England), 2023, 06-19, Volume: 27, Issue:1

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surveys and Questionnaires; Vancomycin

2023
Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model.
    Antimicrobial agents and chemotherapy, 2023, 08-17, Volume: 67, Issue:8

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Drug Therapy, Combination; Glomerular Filtration Rate; Iohexol; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin

2023
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
    European journal of pediatrics, 2023, Volume: 182, Issue:9

    Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin

2023